【geneonline】Taiwan’s Amaran Biotech Takes Top Spot at 2025 Asia-Pacific Biopharma Awards

【Yahoo!Finance】Amaran Biotech Wins Asia-Pacific Biopharma Excellence Award 2025

【Macau Business】Amaran Biotech Wins Asia-Pacific Biopharma Excellence Award 2025

【The Korea Bizwire】Amaran Biotech Wins Asia-Pacific Biopharma Excellence Award 2025

Amaran Biotech Wins Asia-Pacific Biopharma Excellence Award 2025 Breakthrough Adjuvant AB-801 Secures “Bioprocessing Excellence in Taiwan” Honor

New-generation Contract Development and Manufacturing Organization (CDMO) Amaran Biotech has been awarded the prestigious “Bioprocessing Excellence in Taiwan” honor at the Asia-Pacific Biopharma Excellence Awards 2025 ceremony, hosted by renowned consulting firm IMAPAC in Singapore on March 12.

【BioSpectrum Asia】Taiwan's Amaran Biotech signs MoU with Nippon to expand CDMO business

【MedPath】Amaran Biotech Partners with Nippon Fine Chemical to Advance Nanoparticle-Based Drug Manufacturing

【Indian Pharma Post】Amaran Biotech Signs MOU with Nippon Fine Chemical for Nanoparticle Drug CDMO Expansion

【Pharma Source】Amaran Biotech Signs MOU with Nippon Fine Chemical for Nanoparticle Drug CDMO Expansion

【Contract Pharma】Amaran Biotech, Nippon Fine Chemical Sign MOU

【Yahoo!Finance】Amaran Biotech Signs MOU with Nippon Fine Chemical

【Macau Business】Amaran Biotech Signs MOU with Nippon Fine Chemical